Clinical trial

Chinese Longitudinal and Systematic Study of Bioplar Disorder

NCT05480150

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2021-11-01

PhaseNA

Study timeline

Study start (actual)2021-11-01Date precision: day

Registry last updated2022-10-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Bipolar Disorder, Mixedunresolved

Affective; Disorder, Organicunresolved

Interventions

Escitalopram Oxalate TabletsDRUG

Quetiapine Fumarate TabletsDRUG

LurasidoneDRUG · verified · RxNorm: lurasidone

Sponsors & collaborators

First Affiliated Hospital of Zhejiang Universitylead sponsor

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05480150 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.